Literature DB >> 25827281

Blood conservation strategies and the management of perioperative anaemia.

Aryeh Shander1, Mazyar Javidroozi.   

Abstract

PURPOSE OF REVIEW: Anaemia is a global health problem with particularly high prevalence in the perioperative setting and it can significantly affect the patient outcomes. This review addresses new findings on the significance of anaemia and patient blood management (PBM) strategies to prevent and manage anaemia. RECENT
FINDINGS: Studies support the independent deleterious effects of anaemia on mortality, morbidity and quality of life as well as its role as a risk factor for transfusion. Although improved understanding of iron regulators such as hepcidin is expected to revolutionize the field, simple algorithms are useful tools for more effective management of anaemia relying on currently available therapies (such as intravenous iron and erythropoiesis-stimulating agents). Other PBM strategies such as optimization of haemostasis and avoidance of blood loss are effective in preventing anaemia or its exacerbation and improving the outcomes of patients. In addition, more attention should be given to hospital-acquired anaemia (HAA) and its avoidable causes, such as unnecessary diagnostic phlebotomies.
SUMMARY: Despite the high prevalence of anaemia and the significant toll it takes on patients, simple and effective strategies are available to detect, diagnose and treat it.

Entities:  

Mesh:

Year:  2015        PMID: 25827281     DOI: 10.1097/ACO.0000000000000179

Source DB:  PubMed          Journal:  Curr Opin Anaesthesiol        ISSN: 0952-7907            Impact factor:   2.706


  2 in total

1.  Thresholds, triggers or requirements-time to look beyond the transfusion trials.

Authors:  Aryeh Shander; Tae-Yop Kim; Lawrence Tim Goodnough
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

2.  Blood Product Supply in Germany: The Impact of Apheresis and Pooled Platelet Concentrates.

Authors:  Karin Berger; Dorothee Schopohl; Georg Wittmann; Wolfgang Schramm; Helmut Ostermann; Christina Rieger
Journal:  Transfus Med Hemother       Date:  2016-09-15       Impact factor: 3.747

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.